Last reviewed · How we verify
NCT07200505: TRCORE-AH2
Telerehabilitation for Core Stability and Strength in Hereditary Ataxia
NA trial testing TR Mixed CORE Exercices in Hereditary Ataxia in 24 participants. Not yet recruiting.
12 June 2026
Quick facts
| Lead sponsor | Universitat de Lleida |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 9 February 2026 |
| Primary completion | 12 June 2026 |
| Estimated completion | 21 December 2026 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- TR Mixed CORE Exercices
- TR Asyncronous CORE Exercices
Conditions studied
- Hereditary Ataxia — all drugs for Hereditary Ataxia →
Sponsor
Universitat de Lleida
Who can join
18 and older, any sex, with Hereditary Ataxia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a two-arm, controlled clinical trial with a parallel design. Participants will be randomly assigned to an intervention or control group. The study is single-blind, as outcome assessors will be blinded to group allocation, while participants and physiotherapists cannot be blinded due to the nature of the intervention. Consecutive sampling will be applied. For the evaluation of intervention effects (primary and secondary outcomes), the study will follow the Consolidated Standards of Reporting Trials (CONSORT) for non-pharmacological interventions. For the assessment of satisfaction and adherence, a qualitative study will be conducted following the COREQ EQUATOR 17 guidelines to ensure methodological rigor. The intervention will consist of a 12-week home-based exercise program supervised via mixed telerehabilitation (TR). The control group will perform the same program but receive only telephone follow-up. Four assessments will be conducted: baseline (T0), post-intervention (T1), three months follow-up (T2), and six months follow-up (T3).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07200505
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hereditary Ataxia
Currently open trials in the same condition.
- NCT07092358 — Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta · recruiting
Other Universitat de Lleida trials
Trials by the same sponsor.
- NCT06809894 — Management of Non-pharmacologic Delirium With the Use of a Nursing-led E-health Project: a Randonmized Controlled Trial · NA · not yet recruiting
- NCT07381881 — GEL-AID: Safe and Effective Hydration for Institutionalized Older Adults · NA · not yet recruiting
- NCT06912373 — Experiences, Outcomes and Unmet Needs of Caregivers of Children With Cerebral Palsy · not yet recruiting
- NCT06621355 — HemoNIRS: a Paradigm Shift in the Process of Musculoskeletal Rehabilitation of ACL Injuries in Cyclic Sports Athletes. · not yet recruiting
- NCT06536673 — Intervention to Reduce Infectious Complications of Peritoneal Dialysis · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07200505 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitat de Lleida
- Last refreshed: 1 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07200505.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing